A carregar...
The antiviral effect of sorafenib in hepatitis c-related hepatocellular carcinoma
BACKGROUND AND AIM: Sorafenib is currently the only approved systemic therapy shown to have efficacy in the treatment of advanced hepatocellular carcinoma (HCC). Recent studies suggest that hepatitis C (HCV)-related HCC patients derive more clinical benefit from sorafenib than other subgroups, but t...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3682667/ https://ncbi.nlm.nih.gov/pubmed/23094860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12098 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|